Regeneron Asks FDA for Emergency Authorization of Its Covid-19 Antibody Therapy Given to Trump Last Week
Oct 08, 2020
2  Likes 0 Comments
About this Deal
Regeneron says it has applied to the US Food and Drug Administration for emergency use authorization for its experimental monoclonal antibody therapy, the same antibody cocktail given to President Donald Trump Friday after he was diagnosed with the virus.
The biotechnology company confirmed it had submitted the application for the authorization in a statement on its website Wednesday night.
"Under our agreement with the U.S. government for the initial doses of REGN-COV2, if an EUA is granted the government has committed to making these doses available to the American people at no cost and would be responsible for their distribution," the statement said. "At this time, there are doses available for approximately 50,000 patients, and we expect to have doses available for 300,000 patients in total within the next few months.